Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer
- 31 March 2009
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 114 (1-2), 33-39
- https://doi.org/10.1016/j.jsbmb.2008.12.016
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The 38th David A. Karnofsky Lecture: The Paradoxical Actions of Estrogen in Breast Cancer—Survival or Death?Journal of Clinical Oncology, 2008
- Intrinsic Mechanism of Estradiol-Induced Apoptosis in Breast Cancer Cells Resistant to Estrogen DeprivationJNCI Journal of the National Cancer Institute, 2005
- Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawalThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- The emerging role of reactive oxygen species in cancer therapyEuropean Journal Of Cancer, 2004
- Apoptotic Action of 17 -Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In VivoJNCI Journal of the National Cancer Institute, 2003
- Effect of Long-Term Estrogen Deprivation on Apoptotic Responses of Breast Cancer Cells to 17 -EstradiolJNCI Journal of the National Cancer Institute, 2001
- Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathioneBiochemical Pharmacology, 1987
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- Randomized Clinical Trial of Diethylstilbestrol versus Tamoxifen in Postmenopausal Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Influence of Synthetic Oestrogens on Advanced Malignant DiseaseBMJ, 1944